{
    "title": "103_hr615",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``National Breast Cancer Strategy Act \nof 1993''.\n\n TITLE I--ESTABLISHMENT OF OFFICE OF BREAST CANCER AND NATIONAL BREAST \n                           CANCER COMMISSION\n\nSEC. 101. OFFICE OF BREAST CANCER.\n\n    Title XVII of the Public Health Service Act (42 U.S.C. 300uu et \nseq.) is amended by adding at the end the following new section:\n\n``SEC. 1709. ESTABLISHMENT OF OFFICE OF BREAST CANCER.\n\n    ``(a) In General.--There is established an Office of Breast Cancer \nwithin the Office of the Assistant Secretary for Health. The Office \nshall have a Director who shall be appointed by the Secretary. The \nSecretary, acting through the Director, shall carry out this section.\n    ``(b) Duties.--The Secretary shall coordinate, in conjunction with \nthe Director of the National Cancer Institute, the activities of the \nInstitute relating to breast cancer with similar activities of other \nagencies of the Federal Government, including the other agencies of the \nNational Institutes of Health, and with similar activities of other \npublic entities and of private entities.\n\nSEC. 102. ESTABLISHMENT OF NATIONAL BREAST CANCER COMMISSION.\n\n    Title XVII of the Public Health Service Act (42 U.S.C. 300uu et \nseq.), as amended by section 101, is amended by adding at the end the \nfollowing new section:\n\n``SEC. 1710. NATIONAL BREAST CANCER COMMISSION.\n\n    ``(a) Establishment.--There is established a commission to be known \nas the `National Breast Cancer Commission' (in this section referred to \nas the `Commission').\n    ``(b) Study.--The Commission shall conduct a study on current \nefforts in both the public and private sectors relating to the \nprevention, early detection, treatment, education, and research \nrelating to breast cancer.\n    ``(c) Report.--Not later than 1 year after the date on which the \ninitial appointments of the members have been completed under \nsubsection (d), the Commission shall submit to the President and the \nCongress a report containing--\n            ``(1) the results of the study conducted under subsection \n        (b); and\n            ``(2) recommendations relating to such study.\n    ``(d) Number and Appointment.--\n            ``(1) Appointment.--The Commission shall be composed of 15 \n        members as follows:\n                    ``(A) 5 members shall be appointed by the \n                President--\n                            ``(i) 3 of whom shall be--\n                                    ``(I) the Secretary of Health and \n                                Human Services;\n                                    ``(II) the Secretary of Veterans \n                                Affairs; and\n                                    ``(III) the Secretary of Defense;\n                        who shall be nonvoting members, except that, in \n                        the case of a tie vote by the Commission, the \n                        Secretary of Health and Human Services shall be \n                        a voting member; and\n                            ``(ii) 2 of whom shall be selected from the \n                        general public on the basis of such individuals \n                        being specially qualified to serve on the \n                        Commission by reason of their education, \n                        training, or experience.\n                    ``(B) 5 members shall be appointed by the Speaker \n                of the House of Representatives on the joint \n                recommendation of the Majority and Minority Leaders of \n                the House of Representatives.\n                    ``(C) 5 members shall be appointed by the President \n                pro tempore of the Senate on the joint recommendation \n                of the Majority and Minority Leaders of the Senate.\n            ``(2) Congressional committee recommendations.--In making \n        appointments under subparagraphs (B) and (C) of paragraph (1), \n        the Majority and Minority leaders of the House of \n        Representatives and the Senate shall duly consider the \n        recommendations of the Chairmen and Ranking Minority Members of \n        committees with jurisdiction over laws contained in chapter 17 \n        of title 38, United States Code (relating to veterans' health \n        care), title XIX of the Social Security Act (42 U.S.C. 1901 et \n        seq.) (relating to Medicaid), and the Public Health Service Act \n        (42 U.S.C. 201 et seq.) (relating to the Public Health \n        Service).\n            ``(3) Requirements of appointments.--The Majority and \n        Minority leaders of the Senate and the House of Representatives \n        shall--\n                    ``(A) select individuals who are specially \n                qualified to serve on the Commission by reason of their \n                education, training, or experience; and\n                    ``(B) engage in consultations for the purpose of \n                ensuring that the expertise of the 10 members appointed \n                by the Speaker of the House of Representatives and the \n                President pro tempore of the Senate shall provide as \n                much of a balance as possible and, to the greatest \n                extent possible, cover the fields of medicine, science, \n                law, ethics, health-care and social services.\n            ``(4) Term of members.--Members of the Commission (other \n        than members appointed under paragraph (1)(A)(i)) shall serve \n        for the life of the Commission.\n            ``(5) Vacancy.--A vacancy on the Commission shall be filled \n        in the manner in which the original appointment was made.\n    ``(e) Chairman.--Not later than 15 days after the members of the \nCommission are appointed, such members shall select a Chairman from \namong the members of the Commission.\n    ``(f) Quorum.--7 members of the Commission shall constitute a \nquorum, but a lesser number may be authorized by the Commission to \nconduct hearings.\n    ``(g) Meetings.--The Commission shall hold its 1st meeting on a \ndate specified by the Chairman. After the initial meeting, the \nCommission shall meet at the call of the Chairman or a majority of its \nmembers, but shall meet at least 3 times each year during the life of \nthe Commission.\n    ``(h) Pay.--Members of the Commission who are officers or employees \nor elected officials of a government entity shall receive no additional \ncompensation by reason of their service on the Commission.\n    ``(i) Per Diem.--While away from their homes or regular places of \nbusiness in the performance of duties for the Commission, members of \nthe Commission shall be allowed travel expenses, including per diem in \nlieu of subsistence, at rates authorized for employees of agencies \nunder sections 5702 and 5703 of title 5, United States Code.\n    ``(j) Deadline for Appointment.--The members of the Commission \nshall be appointed not later than 60 days after the date of the \nenactment of this section.\n    ``(k) Termination.--The Commission shall cease to exist 60 days \nafter the date on which its final report is submitted under subsection \n(c).''.\n\nTITLE II--DUTIES OF DIRECTOR OF THE NATIONAL CANCER INSTITUTE RELATING \n                            TO BREAST CANCER\n\nSEC. 201. PROVISIONS FOR FULL FUNDING FOR NATIONAL CANCER INSTITUTE \n              WITH RESPECT TO RESEARCH ON BREAST CANCER.\n\n    Section 408(a)(1) of the Public Health Service Act (42 U.S.C. \n284c(a)(1)) is amended by adding at the end the following subparagraph:\n            ``(C) For the purpose of conducting and supporting research \n        on breast cancer through the National Cancer Institute, there \n        is authorized to be appropriated for fiscal year 1994 an amount \n        equal to the sum of $300,000,000 and the amount obligated by \n        such Institute for such research for fiscal year 1993. For such \n        purpose, there are authorized to be appropriated such sums as \n        may be necessary for each of the fiscal years 1995 and 1996.''.\n\nSEC. 202. DUTIES OF DIRECTOR.\n\n    Subpart 1 of part C of title IV of the Public Health Service Act \n(42 U.S.C. 285 et seq.) is amended by adding at the end the following \nnew section:\n\n``SEC. 417. DUTIES OF DIRECTOR OF THE INSTITUTE RELATING TO BREAST \n              CANCER RESEARCH.\n\n    ``(a) The Director of the Institute shall conduct and support \nbiomedical and behavioral research and research training, the \ndissemination of health information, and other programs with respect to \nbreast cancer.\n    ``(b) In carrying out subsection (a), the Director of the Institute \nshall conduct or support multidisciplinary clinical research on breast \ncancer, including research on assisting individuals with such cancers \n(and the families of such individuals) and with responding to \npsychological and social problems that arise as the result of the \ncancer.\n    ``(c)(1) The Director of the Institute shall establish the Rose \nKushner Scholarship Program for the purpose of entering into contracts \nwith individuals under which--\n            ``(A) the Director of the Institute agrees to provide to \n        the individuals scholarships for attendance at accredited \n        health professions schools; and\n            ``(B) the individuals agree--\n                    ``(i) to complete the programs of education for \n                which the scholarships are provided;\n                    ``(ii) to complete a program of postgraduate \n                clinical training in oncology; and\n                    ``(iii) after completing a program of such \n                training, to serve as employees of the National \n                Institutes of Health, for the period described in \n                paragraph (2), in positions that are needed by such \n                Institutes in carrying out programs with respect to \n                breast cancer.\n    ``(2)(A) For purposes of paragraph (1)(B)(iii), the period of \nservice for which an individual is obligated to serve as an employee of \nthe National Institutes of Health is 12 months for each academic year \nfor which the scholarship under such subsection is provided.\n    ``(B) The Director of the Institute may defer the obligation of an \nindividual to provide a period of service under paragraph (1)(B)(iii), \nif the Director determines that such a deferral is appropriate.\n    ``(C) For any period in which an individual provides service as an \nemployee of the National Institutes of Health in satisfaction of the \nobligation of the individual under paragraph (1)(B)(iii), the \nindividual may be appointed as such an employee without regard to the \nprovisions of title 5, United States Code, relating to appointment and \ncompensation.\n    ``(3)(A) The Director of the Institute may not provide a \nscholarship under paragraph (1) for an academic year unless--\n            ``(i) the individual applying for the scholarship has \n        submitted to the Director a proposed academic program for the \n        year and the Director has approved the program; and\n            ``(ii) the individual agrees that the program will not be \n        altered without the approval of the Director.\n    ``(B) The Director of the Institute may not provide a scholarship \nunder paragraph (1) for an academic year unless the individual applying \nfor the scholarship agrees to maintain an acceptable level of academic \nstanding, as determined by the educational institution involved in \naccordance with regulations issued by the Secretary.\n    ``(4)(A) The Director of the Institute may not provide a \nscholarship under paragraph (1) for an academic year in an amount \nexceeding $10,000.\n    ``(B) A scholarship provided under paragraph (1) may be expended \nonly for tuition expenses, other reasonable educational expenses, and \nreasonable living expenses incurred while attending the health \nprofessions school involved.\n    ``(C) In the case of a health professions school with respect to \nwhich a scholarship under paragraph (1) is provided, the Director of \nthe Institute may enter into a contract with the school under which the \namounts provided in the scholarship for tuition and other educational \nexpenses are paid directly to the school. Payments to the school under \nthe contract may be made without regard to section 3324 of title 31, \nUnited States Code.\n    ``(5) The provisions of section 338E shall apply to the program \nestablished in paragraph (1) to the same extent and in the same manner \nas such provisions apply to the National Health Service Corps Loan \nRepayment Program established in section 338B.\n    ``(6) The Director of the Institute may not provide a scholarship \nunder paragraph (1) unless an application for the scholarship is \nsubmitted to the Director and the application is in such form, is made \nin such manner, and contains such agreements, assurances, and \ninformation as the Director determines to be necessary to carry out \nthis section.\n    ``(d)(1) The Director of the Institute shall, subject to paragraph \n(2), carry out a program of entering into contracts with appropriately \nqualified health professionals under which the professionals agree to \ncarry out activities with respect to breast cancer as employees of the \nNational Institutes of Health in consideration of the Federal \nGovernment agreeing to pay, for each year of such service, not more \nthan $20,000 of the principal and interest of the educational loans of \nthe professionals.\n    ``(2) The Director of the Institute may not enter into a contract \nwith a health professional pursuant to paragraph (1) unless the \nprofessional has a substantial amount of educational loans relative to \nincome.\n    ``(3) Except to the extent inconsistent with this section, 338E \nshall apply to the program established in paragraph (1) to the same \nextent and in the same manner as such section applies to the National \nHealth Service Corps Loan Repayment Program established in section \n338B.''.\n\nSEC. 203. SPECIALIZED PROGRAMS OF RESEARCH EXCELLENCE WITH RESPECT TO \n              BREAST, LUNG, AND PROSTATE CANCER.\n\n    Section 408(a)(1) of the Public Health Service Act, as amended by \nsection 201, is amended by adding at the end the following \nsubparagraph:\n            ``(D)(i) For the purpose of carrying out not less than 10 \n        programs for research on breast cancer, lung cancer, or \n        prostate cancer under the programs designated by the Director \n        of the National Cancer Institute as the Specialized Programs of \n        Research Excellence, there is authorized to be appropriated \n        such sums as may be necessary for each of the fiscal years 1994 \n        through 1996.\n            ``(ii) With respect to the purpose described in clause (i), \n        the authorizations of appropriations established in such clause \n        may not be construed as terminating the availability for such \n        purpose of any other authorization of appropriations (including \n        the authorization established in subparagraph (A).''."
}